Lot 16
Italian (1927-2012)
Untitled (Fruit Stand) (1966)

oil on canvas


39 1/2 x 43 1/2 inches


signed lower right

Estimate: $3,000 - $5,000

Have one like this?

Frame Information

frame dimensions: 47 1/2 x 51 1/2 x 3 inches, wood frame


From the Collection of Memorial Sloan Kettering Cancer Center


overall good condition, with 1/2 inch puncture to watermelon on middle right side

Nicola Simbari

Italian 1927-2012

Nicola Simbari, was an Italian painter known for his vibrant and dynamic works. His paintings are characterized by bold colors, energetic brushstrokes, and a sense of movement that captivates the viewer. His unique style blends elements of realism with abstraction, creating visually arresting compositions that evoke emotion and intrigue. Simbari's adeptness in capturing the interplay of light and color on canvas is a hallmark of his work. His use of vibrant hues and dynamic contrasts creates a sense of depth and atmosphere, drawing viewers into his immersive scenes. His vibrant portrayals of landscapes, cityscapes, and figures capture the essence of a bygone era, preserving it for future generations to appreciate.

A selection from

Memorial Sloan Kettering Cancer Center

Image for Collection Memorial Sloan Kettering Cancer Center

Proceeds from this sale will directly benefit The Society of MSK, which was founded in 1946 by a group of forward-thinking women dedicated to enhancing the hospital environment and level of patient support that have always been the hallmarks of MSK. Today, the Society has evolved into a full partner of MSK as an internationally renowned organization involved in both policy and fundraising in support of research, patient care programs and education. 

Memorial Sloan Kettering Cancer Center is the world's oldest and largest private cancer center, providing comprehensive care to patients from all walks of life. Renowned for its cutting-edge research, innovative treatments, and compassionate approach to care, Memorial Sloan Kettering Cancer Center is dedicated to making progress against cancer and improving outcomes for patients worldwide.